Clinical Trial

Assessing Claims of Cannabis as an Anti-cancer Agent (CATA)

Study acronym: CATA
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the study is to find out how cannabis may help control cancer growth by reviewing medical records of patients who report cannabis helped treat their cancer.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-04.
Status change: Recruiting → Active, Not Recruiting 2026-05-05
Trial Details
NCT Number NCT07107607
Lead Sponsor HealthPartners Institute
Conditions Cancer, Cancer (With or Without Metastasis)
Enrollment 50 participants
Start Date 2021-03-19
Primary Completion 2027-01 (estimated)
Study Completion 2027-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-07